Correlation Between Diabetic Peripheral Neuropathy and Sarcopenia in Patients with Type 2 Diabetes Mellitus and Diabetic Foot Disease: A Cross-Sectional Study

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2020 Feb 28

PMID 32104034

Citations 21

Authors

Qin Yang

Yingxiao Zhang

Qinglian Zeng

Chan Yang

Jiale Shi

Chunlin Zhang

Xia Ni

Zhipeng Du

Ziwei Tang

Jinbo Hu

Xuemei Li

Jiahui Cai

Qifu Li

Qingfeng Cheng

Affiliations

Soon will be listed here.

Abstract

Purpose: The present study was designed to determine the relationships between sarcopenia and diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes mellitus (T2DM) and diabetic foot disease (DFD) respectively.

Patients And Methods: A total of 1104 patients with T2DM and 257 patients with DFD were included in the study, which was designed as a cross-sectional study. Body composition was assessed using dual-energy X-ray-absorptiometry (DXA). The diagnosis of sarcopenia was based on the Baumgartner criteria. DPN was assessed by Neuropathy symptom score (NSS) and Neuropathy disability score (NDS), and the severity of neuropathy was divided into non-neuropathy symptom (NS), Mild NS, Moderate NS and Severe NS according to NSS. Logistic regression analyses were carried out to determine the relations of sarcopenia and DPN in patients with T2DM and NSS in patients with DFD, respectively.

Results: The prevalence of DPN was 80.0% in T2DM patients with sarcopenia and 70.3% in non-sarcopenia patients (P=0.007). Logistic regression analyses showed DPN was one of the independent risk factors for sarcopenia in T2DM patients (OR 1.564 [95% CI: 1.004, 2.435], P=0.048). The prevalence of DPN had no statistical significance in DFD patients with or without sarcopenia. However, the NSS of DFD patients with sarcopenia was higher than that of non-sarcopenia patients. In the multivariate logistic regression analysis, NSS was determined to be associated with sarcopenia in DFD patients (OR 1.387[95% CI: 1.074, 1.789], P=0.012). The appendicular lean mass (ALM) of DFD patients without NS was higher than patients with mild, moderate and severe NS (20.71±2.73 vs 16.57±3.62 vs 17.99±3.54 vs 17.23±3.29 Kg, P=0.028).

Conclusion: DPN is an independent risk factor for sarcopenia in patients with T2DM and NSS is also independently correlated with sarcopenia in patients with DFD, with the latter being more obvious with the aggravation of neurological symptoms in DFD patients.

Citing Articles

Understanding the Complexity of Hypertension with Sarcopenia by Scientometric Analysis.

Zou J, Liu Y, Tian C, Wang L, Li S, Ran J J Multidiscip Healthc. 2025; 17:6211-6228.

PMID: 39759086 PMC: 11697656. DOI: 10.2147/JMDH.S498799.

Lipoprotein(a) is Associated with Sarcopenia in Patients with Type 2 Diabetes: A cross-Sectional Study.

Wei W, Lv F, Liu S, Cao H, Lin R, Chen H Diabetes Metab Syndr Obes. 2024; 17:4511-4524.

PMID: 39619221 PMC: 11608542. DOI: 10.2147/DMSO.S489605.

Sarcopenia in the foot on magnetic resonance imaging in patients with diabetes mellitus - a systematic review.

Ahmad M, Mohamed A, Amiras D, Siracusa F, Shalhoub J, Davies A Clin Diabetes Endocrinol. 2024; 10(1):31.

PMID: 39449093 PMC: 11515346. DOI: 10.1186/s40842-024-00194-5.

Causality between sarcopenia and diabetic neuropathy.

Fang Y, Yuan X, Zhang Q, Liu J, Yao Q, Ye X Front Endocrinol (Lausanne). 2024; 15:1428835.

PMID: 39345878 PMC: 11427279. DOI: 10.3389/fendo.2024.1428835.

Type 2 diabetes: is obesity for diabetic retinopathy good or bad? A cross-sectional study.

Chen Z, Zhong X, Lin R, Liu S, Cao H, Chen H Nutr Metab (Lond). 2024; 21(1):68.

PMID: 39160558 PMC: 11334401. DOI: 10.1186/s12986-024-00842-8.

References

Chiu C, Yang R, Sheu M, Chan D, Yang T, Tsai K . Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway. J Pathol. 2015; 238(3):470-82. DOI: 10.1002/path.4674. View

Andersen H, Nielsen S, Mogensen C, Jakobsen J . Muscle strength in type 2 diabetes. Diabetes. 2004; 53(6):1543-8. DOI: 10.2337/diabetes.53.6.1543. View

Andreassen C, Jakobsen J, Andersen H . Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes. 2006; 55(3):806-12. DOI: 10.2337/diabetes.55.03.06.db05-1237. View

Chen L, Liu L, Woo J, Assantachai P, Auyeung T, Bahyah K . Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15(2):95-101. DOI: 10.1016/j.jamda.2013.11.025. View

Schwartz A . Diabetes Mellitus: Does it Affect Bone?. Calcif Tissue Int. 2003; 73(6):515-9. DOI: 10.1007/s00223-003-0023-7. View

Baumgartner R, Koehler K, Gallagher D, Romero L, Heymsfield S, Ross R . Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147(8):755-63. DOI: 10.1093/oxfordjournals.aje.a009520. View

Cheng Q, Hu J, Yang P, Cao X, Deng X, Yang Q . Sarcopenia is independently associated with diabetic foot disease. Sci Rep. 2017; 7(1):8372. PMC: 5566791. DOI: 10.1038/s41598-017-08972-1. View

Andersen H, Stalberg E, Gjerstad M, Jakobsen J . Association of muscle strength and electrophysiological measures of reinnervation in diabetic neuropathy. Muscle Nerve. 1998; 21(12):1647-54. DOI: 10.1002/(sici)1097-4598(199812)21:12<1647::aid-mus4>3.0.co;2-d. View

Horlings C, van Engelen B, Allum J, Bloem B . A weak balance: the contribution of muscle weakness to postural instability and falls. Nat Clin Pract Neurol. 2008; 4(9):504-15. DOI: 10.1038/ncpneuro0886. View

10.

Schwartz A, Vittinghoff E, Sellmeyer D, Feingold K, de Rekeneire N, Strotmeyer E . Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care. 2007; 31(3):391-6. PMC: 2288549. DOI: 10.2337/dc07-1152. View

11.

Kalyani R, Corriere M, Ferrucci L . Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014; 2(10):819-29. PMC: 4156923. DOI: 10.1016/S2213-8587(14)70034-8. View

12.

Ramji N, Toth C, Kennedy J, Zochodne D . Does diabetes mellitus target motor neurons?. Neurobiol Dis. 2007; 26(2):301-11. DOI: 10.1016/j.nbd.2006.11.016. View

13.

Leenders M, Verdijk L, van der Hoeven L, Adam J, van Kranenburg J, Nilwik R . Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc. 2013; 14(8):585-92. DOI: 10.1016/j.jamda.2013.02.006. View

14.

Allen M, Kimpinski K, Doherty T, Rice C . Length dependent loss of motor axons and altered motor unit properties in human diabetic polyneuropathy. Clin Neurophysiol. 2013; 125(4):836-843. DOI: 10.1016/j.clinph.2013.09.037. View

15.

Hilton T, Tuttle L, Bohnert K, Mueller M, Sinacore D . Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys Ther. 2008; 88(11):1336-44. PMC: 2579904. DOI: 10.2522/ptj.20080079. View

16.

Fielding R, Vellas B, Evans W, Bhasin S, Morley J, Newman A . Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011; 12(4):249-56. PMC: 3377163. DOI: 10.1016/j.jamda.2011.01.003. View

17.

Lipsky B, Weigelt J, Sun X, Johannes R, Derby K, Tabak Y . Developing and validating a risk score for lower-extremity amputation in patients hospitalized for a diabetic foot infection. Diabetes Care. 2011; 34(8):1695-700. PMC: 3142050. DOI: 10.2337/dc11-0331. View

18.

Young M, Boulton A, Macleod A, Williams D, Sonksen P . A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993; 36(2):150-4. DOI: 10.1007/BF00400697. View

19.

Kim T, Park M, Yang S, Yoo H, Kang H, Song W . Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010; 33(7):1497-9. PMC: 2890348. DOI: 10.2337/dc09-2310. View

20.

Allen M, Major B, Kimpinski K, Doherty T, Rice C . Skeletal muscle morphology and contractile function in relation to muscle denervation in diabetic neuropathy. J Appl Physiol (1985). 2013; 116(5):545-52. PMC: 3949214. DOI: 10.1152/japplphysiol.01139.2013. View